Celcuity (CELC) Enterprise Value (2016 - 2026)
Celcuity's (CELC) quarterly Enterprise Value came in at -$717.3 million in Q4 2025, down 205.1% YoY from $682.5 million in Q4 2024, and down 57.66% on a QoQ basis from -$455.0 million in Q3 2025.
Celcuity (CELC) Enterprise Value (2016 - 2026) Analysis & Trends
Celcuity (CELC) has 10 years of Enterprise Value data on file, last reported at -$717.3 million in Q4 2025.
- Quarterly Enterprise Value fell 205.1% year-over-year to -$717.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$717.3 million (down 205.1% YoY) and the FY2025 annual result came in at -$717.3 million, down 205.1% from the prior year.
- Enterprise Value slipped to -$717.3 million in Q4 2025, from -$455.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$35.0 million in Q1 2021 to a low of -$717.3 million in Q4 2025.
- A 5-year average of -$187.4 million and a median of -$162.9 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value tumbled 623.06% — and 2025, when it jumped 40.51%.
- Tracing CELC's Enterprise Value over 5 years: stood at -$84.3 million in 2021, then sank by 99.97% to -$168.6 million in 2022, then declined by 7.12% to -$180.6 million in 2023, then plunged by 30.19% to -$235.1 million in 2024, then sank by 205.1% to -$717.3 million in 2025.
- The last three Enterprise Value figures came in at -$717.3 million (Q4 2025), -$455.0 million (Q3 2025), and -$168.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | -1.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.33 Bn |
| Dec 31, 2025 | -717.30 Mn |
| Sep 30, 2025 | -454.98 Mn |
| Jun 30, 2025 | -168.39 Mn |
| Mar 31, 2025 | -205.69 Mn |
| Dec 31, 2024 | -235.10 Mn |
| Sep 30, 2024 | -264.06 Mn |
| Jun 30, 2024 | -283.07 Mn |
| Mar 31, 2024 | -177.66 Mn |
| Dec 31, 2023 | -180.58 Mn |
| Sep 30, 2023 | -133.94 Mn |
| Jun 30, 2023 | -146.24 Mn |
| Mar 31, 2023 | -157.48 Mn |
| Dec 31, 2022 | -168.59 Mn |
| Sep 30, 2022 | -57.51 Mn |
| Jun 30, 2022 | -66.93 Mn |
| Mar 31, 2022 | -78.32 Mn |
| Dec 31, 2021 | -84.31 Mn |
| Sep 30, 2021 | -90.39 Mn |
| Jun 30, 2021 | -41.66 Mn |